Explore Our Top-Tier Instruments and Technologies

Eremid’s genomics labs are equipped with multiple examples of the latest genomics instrumentation, enabling us to support research and clinical genomics projects of different sizes and in different applications quickly and efficiently. Enhanced by advanced robotics, LIMS, and bioinformatics, our capabilities can support and accelerate your projects from concept to delivery.

Pacific Biosciences

Revio

The PacBio Revio system is the latest cutting-edge long-read sequencing platform designed to deliver exceptional accuracy and throughput at scale, meeting the demanding needs of modern research and clinical genomics. Taking advantage of PacBio’s HiFi sequencing technology, the Revio system offers highly accurate long-read sequencing that is ideal for complex genomic analyses, such as de novo genome assembly, detecting rare variants and structural variations, and epigenetic studies.

Generate comprehensive genomic data for everything from microbiome projects to population-scale clinical studies using the scalability and efficiency of the PacBio Revio.

Benefits

  • High accuracy
  • Long-read capability
  • Suitable for complex genomic studies and large-scale projects

Pacific Biosciences

Sequel IIe

For smaller projects, the PacBio Sequel IIe provides cost-effective, and highly accurate HiFi sequencing for whole genome, metagenome, targeted, and RNA sequencing reads of human, plant, animal, and microbial samples. The system makes finding complex variants, structural variations, and insights into genetic diversity straightforward with the ability for expansive reads and full-length transcripts.

Benefits

  • Long-read sequencing
  • High data accuracy
  • Versatility for a wide range of applications

Illumina

NovaSeq 6000

The Illumina NovaSeq 6000 is a versatile, high-throughput next generation sequencing (NGS) system that takes advantage of Illumina’s sequencing-by-synthesis approach. It is suitable for a range of applications from WGS to transcriptomics, and scales easily with rapid run times. The system delivers high accuracy, high quality data, enabling you to tackle complex research and clinical genomics projects with ease.

Benefits

  • Scalability
  • Flexibility
  • High throughput
  • Precision

Illumina

iSeq 100

A compact, benchtop NGS system, the Illumina iSeq 100 offers a flexible, cost-effective platform for smaller-scale genomic projects. Taking advantage of Illumina’s sequencing-by-synthesis approach, the iSeq 100 offers high quality data with relative ease. It is well-suited for targeted panels, smaller genomes, and amplicon sequencing, and offers reliable, efficient data at a lower throughput to its NovaSeq counterpart.

Benefits

  • Cost-efficient
  • Consistent and high-quality sequencing results

Illumina

iScan

The Illumina iScan system is a high-precision, high-throughput microarray scanner designed to generate fast, accurate genotyping, gene expression, and epigenetic data. Offering genotyping, methylation profiling, and cytogenetic analysis, the iScan system offers the combination of precision and speed for large-scale studies, including biomarker discovery.

Benefits

  • High-throughput
  • Precise
  • Support for diverse genomic and epigenomic applications

10x Genomics

Chromium X series

The 10x Genomics Chromium X is a versatile benchtop single-cell and spatial genomics system, enabling low- and high-throughput analysis using a range of 10x Genomics Chromium cell assays. By capturing nucleic acids, proteins, and immunological information from individual cells in droplets, the system enables you to assay thousands to millions of individual cells, delivering unique detailed insights into cell diversity, gene expression, and tissue architecture. The range of scalable single-cell assays, including epigenomics, transcriptomics, and immune profiling, as well as the flexibility to scale up pilot studies make it ideal for supporting research and clinical genomics.

Benefits

  • High throughput
  • Single-cell analysis
  • Scalable for large studies

Nanostring

nCounter

The Nanostring nCounter platform is a powerful solution for multiplexed gene expression analysis. It offers the ability to quantify up to 800 targets simultaneously, accelerating biomarker validation and development workflows. Compatible with a range of sample types (FFPR, FF, blood, etc.) and requiring minimal sample preparation steps, the nCounter system offers actionable data for oncology, immunology, and neuroscience studies.

Benefits

  • High multiplexing capability
  • Direct detection of nucleic acids and proteins
  • Versatile applications

Oxford Nanopore Technologies

MinION

A compact, portable system, the Oxford Nanopore MinION is a DNA and RNA sequencer with long-read capabilities and real-time data output. It is capable of direct sequencing of RNA, without the need for reverse transcription, and is designed to simplify sample preparation and be cost-effective at the lab bench or in the field. It is particularly suitable for smaller-scale projects that benefit from more immediate data like pathogen detection and environmental monitoring, but is also able to support targeted and whole genome sequencing, metagenomics, transcriptomics, and smaller multiplexing studies.

Benefits

  • Real-time data
  • Long-read capabilities
  • Minimal sample preparation steps

Thermo Fisher Scientific

GeneTitanMC

An automated microarray platform, the Thermo Fisher Scientific GeneTitanMC system is designed for high-throughput genotyping and gene expression analysis. Particularly suited for large-scale studies, it is efficient and minimizes the chance of errors by automating workflow steps from hybridization to imaging. It delivers high resolution data for a range of study types, including genome-wide SNP genotyping, biomarker discovery, and CNV analysis.

Benefits

  • Scalability
  • Automated workflow for high consistency and data quality
Looking for deeper insights on your next project? Discuss a project
"Eremid provides the support we need to make a global impact in our large immunogenomic oncology clinical studies. The team’s expertise and flexibility from assay design to data delivery is helping us achieve our vision – an ideal research partner." Geoffrey Erickson, Immunis AI, MI USA — Senior Vice President, Corporate Development
"Working with Eremid has been a pleasure. We received excellent data with a very fast turnaround and appreciated the attentive and helpful project management!" Steve Watkins, BCD Biosciences, CA USA — CEO
Trusted by